A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer’s disease

Main text

(Molecular Therapy 32, 3372–3401; October 2024)

After publication, the authors realized that Dr. Juzoh Umemori was mistakenly not considered an author of the paper. The corrected author list is now updated online.

All authors agreed to this change. Dr. Juzoh Umemori designed the plasmid "pFCK-CaMKIIα-TrkB-ICD-IRES-ZsGreen1" and supervised the construction process and lentivirus generation led by the first author. He also constructed empty vectors for NGS sequencing and managed the shipment of all viruses and plasmids. Furthermore, Dr. Umemori contributed to the manuscript by drafting sections on plasmid construction and lentivirus production, specifically the "LV plasmid generation" and "LV production and purification" sections. Additionally, the authors have also updated the acknowledgments section to include the following: "The service for sucrose purification and titer determination of the lentiviruses was provided by the Biomedicum Functional Genomics Unit at the Helsinki Institute of Life Science and Biocenter Finland at the University of Helsinki."